EMERGENT BIOSOLUTIONS INC. (EBS) Return on equity 2016–2025
EMERGENT BIOSOLUTIONS INC. (EBS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
10.1%FY2025 · since FY2016: 8.7% → 10.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 10.1% | +49.5 pp |
| FY2024 | -39.5% | +77.6 pp |
| FY2023 | -117.1% | -101.9 pp |
| FY2022 | -15.2% | -28.9 pp |
| FY2021 | 13.6% | -7.5 pp |
| FY2020 | 21.1% | +16.1 pp |
| FY2019 | 5.0% | -1.2 pp |
| FY2018 | 6.2% | -2.9 pp |
| FY2017 | 9.1% | +0.4 pp |
| FY2016 | 8.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice